PROCTER & GAMBLE HEALTH L
PGHL · General/Diversified · NSE
₹5,119
Current Market Price
Fair Value (DCF)
₹3,457
Margin of Safety
-32.5%
Updated just now
YieldIQ Score
45/100
Piotroski F-Score
6/9
Economic Moat
Wide
Confidence
66%
ROE
—
Debt/Equity
0.01
WACC
11.1%
Market Cap
₹8,498 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
47.6%
Return on capital employed
EV / EBITDA
21.2×
Enterprise multiple
Debt / EBITDA
0.0×
Leverage vs earnings
Interest Coverage
380.6×
EBIT covers interest
Current Ratio
2.39×
Short-term liquidity
Asset Turnover
1.42×
Revenue per ₹ of assets
Revenue CAGR (3Y)
4.5%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹5,119.3
Bear case
₹1,897.57
MoS -169.8%
Base case
₹3,456.79
MoS -48.1%
Bull case
₹3,923
MoS -30.5%
Ratio Trends
PGHL · last 5 annual periods
ROE
3.1%
ROCE
4.3%
Operating Margin
—
Debt / Equity
—
PE
270.5×
EV / EBITDA
22.2×
Historical Financials
PGHL · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2018 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹849 Cr | ₹1009 Cr | ₹296 Cr | ₹301 Cr | ₹284 Cr | -24.0% |
| EBITDA | — | ₹264 Cr | ₹281 Cr | ₹343 Cr | ₹301 Cr | +3.4% |
| EBIT | ₹158 Cr | ₹234 Cr | ₹54.7 Cr | ₹44.3 Cr | ₹23.0 Cr | -38.2% |
| PAT | ₹839 Cr | ₹177 Cr | ₹41.2 Cr | ₹29.8 Cr | ₹16.8 Cr | -62.4% |
| EPS (diluted) | ₹61.29 | ₹106.50 | ₹24.80 | ₹17.96 | ₹10.11 | -36.3% |
| CFO | — | ₹247 Cr | ₹170 Cr | ₹236 Cr | ₹228 Cr | -2.0% |
| CapEx | — | — | — | — | — | — |
| FCF | — | — | — | — | — | — |
| Total Assets | — | ₹986 Cr | ₹894 Cr | ₹1101 Cr | ₹794 Cr | -5.3% |
| Total Debt | — | — | ₹0.0 Cr | ₹0.0 Cr | ₹0.0 Cr | — |
| Shareholders' Equity | — | — | ₹616 Cr | ₹751 Cr | ₹538 Cr | -3.3% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
PGHL vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
| AKUMS AKUMS | — | — | Pending | 11.0% | — |
| SHILPAMED SHILPAMED | — | — | Pending | 3.3% | — |
| VIYASH VIYASH | — | — | Pending | 2.8% | — |
| STAR STAR | — | — | Pending | 138.9% | — |
| SUDEEPPHRM SUDEEPPHRM | — | — | Pending | 28.1% | — |
Click a ticker to view its fair-value analysis.
Dividend History
No dividend events recorded for PGHL in the last 10 years.
AI Analysis Summary
Model-generated description of metrics. Not investment advice. PROCTER & GAMBLE HEALTH L (PGHL.NS) trades at 5119.30 vs a model fair value of 3456.79, a gap of -32.5%. Piotroski F-score: 6/9. Moat lab...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of PGHL →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for PGHL →
Compare
Head-to-head with peers
Compare PGHL side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse PGHLNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.